This is a preview of subscription content, log in via an institution to check access.
Reference
Lauk O, et al. The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis. Frontiers in Oncology 10: 13 Nov 2020. Available from: URL: http://doi.org/10.3389/fonc.2020.588563
Rights and permissions
About this article
Cite this article
Antineoplastics/bevacizumab. Reactions Weekly 1869, 46 (2021). https://doi.org/10.1007/s40278-021-00911-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-00911-3